A Rare Case of Drug-Induced Erectile Dysfunction with Secukinumab Solved After Switch to Ixekizumab in A Psoriatic Patient: A Case Report.
CONCLUSION: We describe for the first time a sexual dysfunction possibly due to secukinumab and his resolution after switch to another similar but different drug, highlighting the potential difference between anti-IL17A drugs.
PMID: 31362662 [PubMed - as supplied by publisher]
Source: Current Drug Safety - Category: Drugs & Pharmacology Authors: Dastoli S, Iannone LF, Bennardo L, Silvestri M, Palleria C, Nisticò SP, De Sarro G, Russo E Tags: Curr Drug Saf Source Type: research
More News: Drugs & Pharmacology | Erectile Dysfunction | Psoriasis | Sexual Dysfunction | Skin | Urology & Nephrology